Published in Drug Week, October 14th, 2011
"Metabolites 3 and 5 exhibited moderate cytotoxicity...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.